Treatment of recurrent erythema nodosum leprosum with infliximab

被引:52
作者
Faber, William R. [1 ]
Jensema, Annigje J. [1 ]
Goldschmidt, Wouter F. M. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1056/NEJMc052955
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:739 / 739
页数:1
相关论文
共 5 条
[1]   TUMOR-NECROSIS-FACTOR PRODUCTION IN PATIENTS WITH LEPROSY [J].
BARNES, PF ;
CHATTERJEE, D ;
BRENNAN, PJ ;
REA, TH ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1992, 60 (04) :1441-1446
[2]   THE INFLUENCE OF THALIDOMIDE ON THE CLINICAL AND IMMUNOLOGICAL MANIFESTATION OF ERYTHEMA-NODOSUM LEPROSUM [J].
SAMPAIO, EP ;
KAPLAN, G ;
MIRANDA, A ;
NERY, JAC ;
MIGUEL, CP ;
VIANA, SM ;
SARNO, EN .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) :408-414
[3]   INVITRO TUMOR-NECROSIS-FACTOR PRODUCTION BY MONONUCLEAR-CELLS FROM LEPROMATOUS LEPROSY PATIENTS AND FROM PATIENTS WITH ERYTHEMA-NODOSUM LEPROSUM [J].
SANTOS, DO ;
SUFFYS, PN ;
BONIFACIO, K ;
MARQUES, MA ;
SARNO, EN .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 67 (03) :199-203
[4]  
SARNO EN, 1991, CLIN EXP IMMUNOL, V84, P103
[5]   Biology of tumor necrosis factor-α -: implications for psoriasis [J].
Schottelius, AJG ;
Moldawer, LL ;
Dinarello, CA ;
Asadullah, K ;
Sterry, W ;
Edwards, CK .
EXPERIMENTAL DERMATOLOGY, 2004, 13 (04) :193-222